These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 20737138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
    Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K.
    Lung Cancer; 2008 Aug; 61(2):235-43. PubMed ID: 18281122
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble mesothelin-related protein--a blood test for mesothelioma.
    Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I.
    Lung Cancer; 2005 Jul; 49 Suppl 1():S109-11. PubMed ID: 15950789
    [Abstract] [Full Text] [Related]

  • 7. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
    Amati M, Tomasetti M, Mariotti L, Tarquini LM, Valentino M, Santarelli L.
    Mutat Res; 2008 Jul; 655(1-2):52-8. PubMed ID: 18638565
    [Abstract] [Full Text] [Related]

  • 8. Serum and pleural fluid biomarkers for mesothelioma.
    Creaney J, Robinson BW.
    Curr Opin Pulm Med; 2009 Jul; 15(4):366-70. PubMed ID: 19417672
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
    Filiberti R, Marroni P, Spigno F, Merlo DF, Mortara V, Caruso P, Cioè A, Michelazzi L, Bruzzone A, Bobbio B, Simonassi C, Del Corso L, Galli R, Racchi O, Dini G, Linares R, Mencoboni M.
    Oncology; 2014 Jul; 86(1):33-43. PubMed ID: 24401539
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
    Demir M, Kaya H, Taylan M, Ekinci A, Yılmaz S, Teke F, Sezgi C, Tanrikulu AC, Meteroglu F, Senyigit A.
    Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653
    [Abstract] [Full Text] [Related]

  • 12. Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos.
    Pesch B, Taeger D, Johnen G, Gross IM, Weber DG, Gube M, Müller-Lux A, Heinze E, Wiethege T, Neumann V, Tannapfel A, Raithel HJ, Brüning T, Kraus T.
    Int J Hyg Environ Health; 2010 Jan; 213(1):44-51. PubMed ID: 19783208
    [Abstract] [Full Text] [Related]

  • 13. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
    Scherpereel A, Grigoriu B, Conti M, Gey T, Grégoire M, Copin MC, Devos P, Chahine B, Porte H, Lassalle P.
    Am J Respir Crit Care Med; 2006 May 15; 173(10):1155-60. PubMed ID: 16456138
    [Abstract] [Full Text] [Related]

  • 14. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
    Creaney J, Robinson BW.
    Hematol Oncol Clin North Am; 2005 Dec 15; 19(6):1025-40, v. PubMed ID: 16325121
    [Abstract] [Full Text] [Related]

  • 15. [Biomarkers for prevention and early diagnosis of malignant pleural mesothelioma].
    Amati M, Tomasetti M, Scartozzi M, Mariotti L, Ciuccarelli M, Valentino M, Governa M, Santarelli L.
    G Ital Med Lav Ergon; 2007 Dec 15; 29(3 Suppl):335-8. PubMed ID: 18409713
    [Abstract] [Full Text] [Related]

  • 16. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
    Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW.
    Chest; 2007 Oct 15; 132(4):1239-46. PubMed ID: 17646232
    [Abstract] [Full Text] [Related]

  • 17. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma.
    Shiomi K, Hagiwara Y, Sonoue K, Segawa T, Miyashita K, Maeda M, Izumi H, Masuda K, Hirabayashi M, Moroboshi T, Yoshiyama T, Ishida A, Natori Y, Inoue A, Kobayashi M, Sakao Y, Miyamoto H, Takahashi K, Hino O.
    Clin Cancer Res; 2008 Mar 01; 14(5):1431-7. PubMed ID: 18316566
    [Abstract] [Full Text] [Related]

  • 18. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
    Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A.
    N Engl J Med; 2005 Oct 13; 353(15):1564-73. PubMed ID: 16221779
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.
    Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, Neri M, Ceppi M, Paganuzzi M, Ivaldi GP, Mencoboni M, Canessa PA, Ambrosino N, Chella A, Mutti L, Puntoni R.
    Clin Cancer Res; 2007 Sep 01; 13(17):5076-81. PubMed ID: 17785560
    [Abstract] [Full Text] [Related]

  • 20. Biomarkers for mesothelioma.
    Scherpereel A, Lee YC.
    Curr Opin Pulm Med; 2007 Jul 01; 13(4):339-443. PubMed ID: 17534183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.